People · Operator
Named in public records as an officer, director or promoter · active 2019–2021 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kiffik Biomedical, Inc. | — | Biotechnology | Pre-Seed | $830K | $21.4M | 2021 |
| Signati Medical, Inc. | — | Healthtech | Pre-Seed | $170K | $5.9M | 2019 |
Nicholas Marr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicholas Marr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| George Cagna | 2 | 3 |
| Brian Dougan | 2 | 2 |
| John Maloney | 1 | 2 |
| Jim Marrotte | 1 | 1 |
| Anthony Mulone | 1 | 1 |
| Robert Van Wyck | 1 | 1 |
| Warren Nighan | 1 | 1 |
| William Prentice | 1 | 1 |
| Blake Carver | 1 | 1 |
| Howard Peterson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.